Integral Derivatives’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Integral Derivatives's AGN Position: Q4 2017 in Review
Integral Derivatives sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 12,594 shares — an estimated $2.26M sold.
Integral Derivatives first reported a position in AGN in Q4 2013 and held it in 15 quarters. The position peaked at $8.62M in Q4 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.
- Integral Derivatives reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
- Integral Derivatives sold 12,594 Allergan plc shares in Q4 2017, an estimated $2.26M.
- Integral Derivatives first reported a position in Allergan plc in Q4 2013 and held it in 15 quarters.
- Integral Derivatives's Allergan plc position peaked at $8.62M in Q4 2016.
- 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.
Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.